[go: up one dir, main page]

ZA896672B - Fatty acid therapy and compositions - Google Patents

Fatty acid therapy and compositions

Info

Publication number
ZA896672B
ZA896672B ZA896672A ZA896672A ZA896672B ZA 896672 B ZA896672 B ZA 896672B ZA 896672 A ZA896672 A ZA 896672A ZA 896672 A ZA896672 A ZA 896672A ZA 896672 B ZA896672 B ZA 896672B
Authority
ZA
South Africa
Prior art keywords
compositions
fatty acid
acid therapy
therapy
fatty
Prior art date
Application number
ZA896672A
Inventor
David Frederick Horrobin
Frederick Horrobin David
John Charles Marshall Stewart
Charles Marshall Stewart John
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Publication of ZA896672B publication Critical patent/ZA896672B/en

Links

ZA896672A 1988-09-13 1989-08-31 Fatty acid therapy and compositions ZA896672B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888821466A GB8821466D0 (en) 1988-09-13 1988-09-13 Fatty acid therapy & compositions

Publications (1)

Publication Number Publication Date
ZA896672B true ZA896672B (en) 1990-06-27

Family

ID=10643526

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896672A ZA896672B (en) 1988-09-13 1989-08-31 Fatty acid therapy and compositions

Country Status (2)

Country Link
GB (1) GB8821466D0 (en)
ZA (1) ZA896672B (en)

Also Published As

Publication number Publication date
GB8821466D0 (en) 1988-10-12

Similar Documents

Publication Publication Date Title
AU4081489A (en) Fatty acid therapy and compositions
ZA895512B (en) Fatty acid composition
DE3666855D1 (en) Alcalisilicate compositions and their use
NZ222980A (en) 3-aryloxy-3-substituted propanamines and pharmaceutical compositions
NZ223096A (en) Peptidylaminodiols and pharmaceutical compositions
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
IL78934A0 (en) Alfuzosine compositions and use
NZ215183A (en) Fluorobenzyl esters and insecticidal compositions
IL75325A0 (en) Immunostimulating agents containing certain substituted quinolone-carboxylic acids and their preparation
IL87800A0 (en) Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ216971A (en) Phosphonate esters and pharmaceutical compositions
NZ226450A (en) Crystalline-1-carbacephalosporin and pharmaceutical compositions
GB8808758D0 (en) Nutritional and medicinal compositions
GR860075B (en) Compositions their preparation and use
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
EP0230052A3 (en) Immunoamplifiers and related compositions
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
NZ219748A (en) Indenopyrimidines and pharmaceutical compositions
NZ218614A (en) 16,17-butylidenedioxy-6,9-difluoro-11-hydroxy-3, 20-dioxopregna-1,4-diene-21-oic acid esters and pharmaceutical compositions
NZ220946A (en) Substituted fluorobenzyl esters and pesticidal compositions
EP0411415A3 (en) Polyethercarboxylic esters and their preparation
ZA896672B (en) Fatty acid therapy and compositions